 SOUTH SAN FRANCISCO, Calif., Sept. 07, 2021 GLOBE NEWSWIRE -- Cytokinetics, Incorporated Nasdaq: CYTK today announced it will host a conference call and webcast on September 13, 2021 at 8:30 AM Eastern Time to discuss the full results from REDWOOD-HCM Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM. Members of Cytokinetics management will be joined by Marty Maron, M.D., Director, Hypertrophic Cardiomyopathy Center; Director, Cardiac CT and MRI; Tufts University School of Medicine, and Principal Investigator of REDWOOD-HCM, and Ahmad Masri, M.D., Assistant Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health Science University. The results are being presented in a Late Breaking Clinical Trials session at the Heart Failure Society of America HFSA Annual Scientific Meeting on September 12, 2021. 